Wnt-1



Wnt-1

A1AA1N2NN2S3SS3S4SS4G5GG5R6RR6W7WW7W8WW8G9GG9I10II10V11VV11N12NN12V13VV13A14AA14S15SS15S16SS16T17TT17N18NN18L19LL19L20LL20T21TT21D22DD22S23SS23K24KK24S25SS25L26LL26Q27QQ27L28LL28V29VV29L30LL30E31EE31P32PP32S33SS33L34LL34Q35QQ35L36LL36L37LL37S38SS38R39RR39K40KK40Q41QQ41R42RR42R43RR43L44LL44I45II45R46RR46Q47QQ47... and 296 more residue(s)...... and 296 more residue(s)

SMILES None
InChIKey None
Sequence ANSSGRWWGIVNVASSTNLLTDSKSLQLVLEPSLQLLSRKQRRLIRQNPGILHSVSGGLQSAVRECKWQFRNRRWNCPTAPGPHLFGKIVNRGCRETAFIFAITSAGVTHSVARSCSEGSIESCTCDYRRRGPGGPDWHWGGCSDNIDFGRLFGREFVDSGEKGRDLRFLMNLHNNEAGRTTVFSEMRQECKCHGMSGSCTVRTCWMRLPTLRAVGDVLRDRFDGASRVLYGNRGSNRASRAELLRLEPEDPAHKPPSPHDLVYFEKSPNFCTYSGRLGTAGTAGRACNSSSPALDGCELLCCGRGHRTRTQRVTERCNCTFHWCCHVSCRNCTHTRVLHECL

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


No bioactivity data available.

Wnt-1

A1AA1N2NN2S3SS3S4SS4G5GG5R6RR6W7WW7W8WW8G9GG9I10II10V11VV11N12NN12V13VV13A14AA14S15SS15S16SS16T17TT17N18NN18L19LL19L20LL20T21TT21D22DD22S23SS23K24KK24S25SS25L26LL26Q27QQ27L28LL28V29VV29L30LL30E31EE31P32PP32S33SS33L34LL34Q35QQ35L36LL36L37LL37S38SS38R39RR39K40KK40Q41QQ41R42RR42R43RR43L44LL44I45II45R46RR46Q47QQ47... and 296 more residue(s)...... and 296 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.